IL-33 accelerates orthodontic tooth movement by promoting M1 differentiation of macrophages and osteoclast formation Authors: Zhengquan He, Huan Tian, Xingyu Liu, Yige Duan, Mengshan Chen, Zhenyan Luo Published: 2026 ABSTRACT AbstractDeveloping methods to promote tooth movement can help reduce the duration of orthodontic treatment for patients. A mouse model of orthodontic tooth movement (OTM) was established to analyze the key role of the IL-33/ST2 signaling pathway in this process. Human periodontal ligament fibroblasts (hPDLFs) and human CD14+ monocytes were isolated to investigate the effect of IL-33/ST2 signaling on directed cell differentiation. Orthodontic mechanical force induced the protein expression of IL-33 and ST2 in periodontal tissues. Injection of recombinant mouse IL-33 protein (10 µl, 10 µg/mL, every other day) accelerated tooth movement, increased the proportion of proinflammatory macrophages (CD45+CD11b+F4/80+Ly6C+), decreased the proportion of reparative macrophages (CD45+CD11b+F4/80+CD206+), and upregulated the expression of cathepsin K in periodontal tissues. In contrast, injection of anti-mouse ST2 antibody (10 µl, 100 µg/mL, every other day) exerted the opposite effects. THRA was identified as a transcriptional activator of IL-33 in hPDLFs, and its expression was also induced by orthodontic mechanical force. Additionally, the IL-33/ST2 signaling pathway promoted osteoclast differentiation of human monocytes. IL-33 accelerates OTM by promoting M1 differentiation of macrophages and osteoclast formation.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-56563-w.Keywords: Orthodontic tooth movement, IL-33, Macrophages, Periodontal ligament fibroblasts, OsteoclastsSubject terms: Cell biology, Diseases, Immunology, Medical research Introduction Orthodontic tooth movement (OTM) refers to the process in which mechanical force is applied to periodontal tissues to drive tooth displacement, thereby correcting malocclusion while preserving dental health. Alveolar bone remodeling constitutes the biological basis of OTM1. The periodontal ligament (PDL) is a fibrous structure that connects the cementum surface at the root to the alveolar bone, anchoring the tooth within the alveolus2. Upon application of lateral force, local ischemia occurs on the compression side of the PDL due to vascular compression3. Such alterations in the microenvironment stimulate periodontal ligament fibroblasts (PDLFs) and immune cells (primarily neutrophils) to release immune mediators, recruit leukocytes (mainly monocytes and macrophages), and further promote osteoclastogenesis, leading to alveolar bone resorption on the compression side4–6. In contrast, cementum exhibits low sensitivity to mechanical force and does not undergo remodeling similar to alveolar bone1. Consequently, the intact tooth is ultimately able to move within the alveolar bone to relieve the mechanical compression on the PDL1. Macrophages and osteoclasts are key cell types involved in alveolar bone remodeling on the compression side. Pro-inflammatory (M1) macrophages are not only responsible for removing necrotic tissue, but also facilitate the rapid proliferation and activation of osteoclasts, thereby promoting alveolar bone resorption and tooth movement7. First, M1 macrophages induce osteoclastogenesis by secreting tumor necrosis factor (TNF)-α and interleukin (IL)-1β, whereas IL-4 and IL-10 released by M2 macrophages inhibit osteoclastogenesis. An elevated M1/M2 macrophage ratio elicits a more pronounced pro-inflammatory effect and enhances osteoclast formation. Second, macrophage activation leads to a reduction in pH and demineralization of the surface on the alveolar bone, providing attachment sites for osteoclasts. We hypothesized that during OTM, accelerating tooth movement and shortening orthodontic treatment duration could be achieved by promoting M1 polarization of macrophages and osteoclastogenesis. However, simply increasing mechanical force or elevating the levels of M1 macrophage-secreted factors such as IL-1 and TNF-αdoes not accelerate tooth movement8. Interleukin-33 (IL-33) belongs to the IL-1 family. It is abundantly expressed in endothelial cells, epithelial cells, and fibroblast-like cells, rather than CD45+ hematopoietic cells, during both homeostasis and inflammation9. Upon cellular injury, IL-33 is released extracellularly and targets tissue-resident immune cells constitutively expressing growth stimulation expressed gene 2 (ST2), thereby participating in the pathogenesis of various allergic and non-allergic diseases9. ST2 is a specific receptor for IL-33. Based on a mouse model of OTM and in vitro cell experiments, this study analyzed the crucial role of IL-33/ST2 signaling in accelerating tooth movement by promoting M1 polarization of macrophages and osteoclastogenesis during OTM. Results Orthodontic mechanical force induces IL-33/ST2 signaling in periodontal tissues During 12 days of orthodontic mechanical force application (Fig. 1A and B), the protein levels of IL-33 and ST2 in periodontal tissues gradually increased (Fig. 1C). Furthermore, IL-33 protein expression was not observed in normal periodontal tissues (Fig. 1C and D). Compared with the maxillary left first molar subjected to orthodontic mechanical force for 12 days, no IL-33 expression and low ST2 expression were detected in the periodontal tissues of the contralateral maxillary right first molar (Fig. 1D). Orthodontic mechanical force induces IL-33/ST2 signaling in periodontal tissues. (A) OTM mouse model. (B) Maxillary left first molar. The white arrow indicates the direction of the force. (C) The protein levels of IL-33 and ST2 in periodontal tissues of maxillary left first molar over 12 days of orthodontic mechanical force application. (D) The protein levels of IL-33 and ST2 in periodontal tissues of the maxillary left and right first molars (12 days of force application). (E) Identification of ST2+ and CD11b+ cells. (F) The expression of ST2 in dental tissues of the maxillary left and right first molars (12 days of force application). The yellow box indicates the compression side. Moreover, flow cytometry analysis revealed that ST2 was primarily expressed in myeloid monocytes, with CD11b+ cells accounting for approximately 80–90% of ST2+ cells (Fig. 1E). In addition, ST2 was expressed at low levels in normal gingival fibroblasts and periodontal ligament cells (contralateral right maxillary first molar, Fig. 1F), whereas it was significantly highly expressed in the PDL tissue of the left maxillary first molar subjected to orthodontic mechanical force for 12 days, especially on the compression side (Fig. 1F). IL-33 promotes pro-inflammatory differentiation of macrophages, osteoclastogenesis and tooth movement To investigate the role of IL-33/ST2 signaling during OTM, recombinant mouse IL-33 protein (10 µL, 10 µg/mL, injected every other day) and anti-mouse ST2 antibody (10 µL, 100 µg/mL, injected every other day) were injected into the buccal side of the left maxillary first molar in OTM mice. As shown in Fig. 2A, recombinant mouse IL-33 protein accelerated tooth movement, whereas anti-mouse ST2 antibody inhibited tooth movement. IL-33 promotes proinflammatory differentiation of macrophages, osteoclastogenesis and tooth movement. The tooth movement distance of maxillary left first molar (A) and the proportions of different macrophage subsets (B and C) in the OTM mouse model, or injected of recombinant mouse IL-33 protein or anti-mouse ST2 antibody. The white arrow indicates the direction of the force. The measurement sites of the vernier caliper are circled by the yellow boxes. The expression level of cathepsin K in periodontal tissues detected by western blot (D). N = 10, * P < 0.05, *** P < 0.001. Moreover, compared with the Sham group, the proportion of pro-inflammatory macrophages (M1 type, CD45+CD11b+F4/80+Ly6C+) was significantly increased, while the proportion of reparative macrophages (M2 type, CD45+CD11b+F4/80+CD206+) was significantly decreased in the periodontal tissues of the OTM group (Fig. 2B and C). Furthermore, compared with the OTM group, IL-33 further promoted the pro-inflammatory differentiation of macrophages, with a significantly increased proportion of CD45+CD11b+F4/80+Ly6C+ cells and a significantly decreased proportion of CD45+CD11b+F4/80+CD206+ cells (Fig. 2B and C). Targeted ablation of ST2 exhibited the opposite effects to IL-33 (Fig. 2B and C). In addition, detection of the expression level of cathepsin K, a specific marker for mature osteoclasts in periodontal tissues, showed that OTM induced osteoclastogenesis, IL-33 further promoted osteoclastogenesis, and targeted ablation of ST2 significantly inhibited osteoclastogenesis (Fig. 2D). These results suggest that IL-33/ST2 signaling may promote tooth movement during OTM by facilitating M1 differentiation of macrophages and osteoclastogenesis. IL-33/ST2 signaling promotes osteoclast differentiation of human monocytes To further verify the finding that IL-33 promoted osteoclastogenesis in periodontal tissues in the mouse model, this study examined the effect of IL-33/ST2 signaling on osteoclastic differentiation of human monocytes cultured in vitro. As shown in Fig. 5A, ST2 was prominently expressed on the surface of human CD14+ monocytes. Macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-κB ligand (RANKL) directly regulate the differentiation of monocytes into osteoclasts (Fig. 3B and C)10. Treatment with M-CSF + IL-33 exerted a similar effect to M-CSF+sRANKL, and significantly induced osteoclastic differentiation of monocytes (Fig. 3B and C), whereas blockade of ST2 abolished the ability of M-CSF + IL-33 to induce osteoclastic differentiation (Fig. 3B and C). IL-33/ST2 signaling promotes osteoclast differentiation of human monocytes. (A) Identification of ST2+ and CD14+ cells. (B and C) The osteoclast detected by TRAP stain. N = 3, *** P < 0.001. THRA activates IL-33 transcription in human PDLFs Finally, this study explored the specific mechanism by which orthodontic mechanical force induces upregulated IL-33 expression. Using UCSC and JASPAR databases, thyroid hormone receptor alpha (THRA) was predicted to be a potential transcriptional activator of IL-33 (Fig. 4A). PDLFs account for 50–60% of PDL cells, and are the primary mechanosensitive cells in the PDL11. To verify that THRA may be responsible for the transcriptional activation and upregulated expression of IL-33 in response to mechanical force, this study achieved overexpression of THRA in human PDLFs (hPDLFs) via transfection with an expression plasmid (Fig. 4B and Sup. Figure 1), and found that overexpression of THRA in hPDLFs activated IL-33 expression (Fig. 4B). Dual-luciferase reporter assays further confirmed that THRA activated the transcription and expression of the target gene by binding to the predicted site (Fig. 4C). When the binding sites were mutated (Pro-Mut), THRA protein failed to activate the transcription and expression of the target gene (Fig. 4C). THRA activates IL-33 transcription in hPDLFs. (A) The predicted THRA-binding sequence on the IL-33 gene promoter sequence. Data were obtained from the UCSC and JASPAR databases. (B) The IL-33 expression in THRA overexpressed hPDLFs. (C) Dual-luciferase reporter assays. Pro-WT, wild-type IL-33 gene promoter sequence; Pro-Mut, predicted site-mutated IL-33 gene promoter sequence. (D) THRA protein in periodontal tissues of maxillary left first molar. (E) The protein levels of THRA in periodontal tissues of maxillary left first molar over 12 days of orthodontic mechanical force application. (F) The protein levels of THRA in periodontal tissues of the maxillary left and right first molars. *P < 0.05. In addition to results from in vitro cellular experiments, data from the OTM mouse model also provided evidence. Consistent with the expression trend of IL-33, increased THRA expression was also detected in the periodontal tissues of the maxillary left first molar in the OTM group (12 days of force application) (Fig. 4D). Over 12 days of orthodontic mechanical force application, the protein level of THRA in periodontal tissues gradually increased (Fig. 4E). The expression level of THRA in the periodontal tissues of the contralateral maxillary right first molar further confirmed that orthodontic mechanical force induced the upregulation of THRA expression (Fig. 4F). The consistent expression trend of THRA and IL-33 proteins during OTM provided indirect evidence that THRA is responsible for the transcriptional activation and upregulated expression of IL-33. Discussion Based on the OTM mouse model, this study found that orthodontic mechanical force induces the expression of IL-33 in periodontal tissues. A study by Jin et al. also demonstrated that orthodontic loading induces IL-33 expression in the PDL12. However, the longitudinal expression patterns of IL-33 over time during OTM differed between the two studies. Jin et al. reported that IL-33 expression in the PDL increased sharply on the first day of orthodontic force application, gradually decreased until day 7, and then remained stable until day 14. Within 14 days of force application, the expression level of IL-33 was significantly higher than that in the control group. In contrast, under the same conditions of applied orthodontic force magnitude (30 g), force application method (closed coil spring), mouse strain (C57BL/6J), and sex (male), the results of this study showed that IL-33 expression was first detectable on day 3 after force application, gradually increased over time, peaked on day 9, and remained elevated until day 12. Additional differences between the two studies included mouse age (6–8 weeks VS. 8 weeks), anesthesia method (intraperitoneal injection of 10% chloral hydrate VS. intraperitoneal injection of 10 ml/kg anesthetic mixture), and euthanasia method (excessive CO2 inhalation VS. 5% isoflurane anesthesia). Using immunohistochemical (IHC) staining, Jin et al. clearly showed that IL-33 was concentrated in the PDL, and not expressed in alveolar bone or dentin12. In the present study, however, western blot was used to detect IL-33 expression in periodontal tissues, which include both the PDL and alveolar bone. The presence of a large amount of alveolar bone tissue may have diluted the relatively low expression level of IL-33, making it harder to detect in the early stage and thus delaying the observed onset of IL-33 expression. Nevertheless, this factor alone cannot fully explain the discrepancy in the longitudinal IL-33 expression patterns between the two studies. Notably, the temporal expression profile of IL-33 in this study is largely consistent with the process of macrophage recruitment and differentiation during OTM. Previous research has shown that the number of M1 macrophages increases significantly on day 3 of OTM, reaches a peak on day 7, and remains stable until day 14 before declining13. Additionally, this study found that the expression level of ST2 in periodontal tissues also increased gradually with the duration of orthodontic force application. ST2 is mainly expressed on monocytes, and this gradual increase may be attributed to the progressive recruitment and accumulation of monocytes during OTM. Using western blot, we did not detect IL-33 protein expression in normal mouse periodontal tissues or hPDLFs. Consistently, Jin et al. also failed to detect IL-33 protein expression in normal mouse periodontal tissues12. In contrast, Lou et al. detected extremely low levels of IL-33 expression in normal mouse periodontal tissues via IHC staining, and observed strong IL-33 expression in hPDLFs using western blot, though the specific information of the antibodies used was not provided in their study14. More importantly, this study further confirmed that the IL-33/ST2 signaling pathway can promote M1 polarization of macrophages and osteoclast formation, thereby accelerating tooth movement. This finding aligns with previous conclusions: systemic infusion of M1 macrophages can promote bone resorption and OTM, while infusion of M2 macrophages exerts no significant effect on OTM15. Depletion of monocytes/macrophages significantly blocks OTM and reduces osteoclast formation15. Notably, M1 macrophage agonists (such as TNF-α) released by other immune cells do not significantly promote OTM16. In contrast, IL-33 secreted by PDLFs can promote OTM, which highlights the critical role of PDLFs in the OTM process. In a diabetes-related periodontitis model established by Lou et al., the IL-33/ST2 signaling pathway was found to reduce the proportion of F4/80+iNOS+ M1 macrophages, increase the proportion of F4/80+CD206+ M2 macrophages, and inhibit osteoclast formation, thereby reducing alveolar bone loss14. The role of the IL-33/ST2 signaling pathway in diabetes-related periodontitis appears to be completely opposite to its role in OTM. This discrepancy may be due to the presence of other immunomodulatory mediators, which interact with the IL-33/ST2 signaling pathway to jointly determine the direction of macrophage differentiation and the formation of osteoclasts and osteoblasts. The responses driven by IL-33 are subtly dependent on the tissue microenvironment. Currently, the promoting or inhibitory effects of IL-33/ST2 on osteoclastogenesis, bone resorption, and bone loss in alveolar bone and other bone tissues under physiological and pathological conditions remain controversial. The effects of IL-33/ST2 exhibit significant differences related to sex, bone site, cell type, loss‑ or gain‑of‑function, and pathological model. The complex mechanisms underlying its function lead to these discrepancies. Phenotypic trends in IL-33 KO mice and IL-33 overexpressing mice are inconsistent and are site‑dependent and sex‑dependent. Louisy et al. reported that trabecular bone volume/total volume ratio in the maxilla was significantly increased in both male and female IL-33 KO mice compared with wild-type mice, whereas no such changes were observed in the femur and fifth lumbar vertebra17. Aida et al. reported no significant differences in femoral bone mineral density and bone strength in male IL-33 KO mice compared with wild-type male mice18. However, bone mineral density in the lumbar vertebra and distal femur was significantly higher in female IL-33 KO mice than in wild-type female mice18. Furthermore, overexpression of IL-33 resulted in a significant and rapid decrease in bone volume, mineral density, and strength, accompanied by increased osteoclast numbers and elevated bone resorption markers compared with wild-type mice18. Most data are derived from mice, with very few data available from human samples. Consistent with the results of the present study, several studies have reported that IL-33/ST2 stimulates functional osteoclast formation from human CD14⁺ monocytes in vitro independently of RANKL19,20. However, some studies have suggested that this effect is relatively weak21,22. IL-33 can promote OTM by facilitating M1 polarization of macrophages and osteoclast formation (Fig. 5). However, its role in immune responses and bone remodeling processes associated with oral diseases requires further investigation. IL-33 accelerates OTM by promoting M1 differentiation of macrophages and osteoclast formation. Methods Establishment of the OTM mouse model All animal experiments were approved by the Animal Care and Use Committee of the Beijing Kewei Animal Technology Co., Ltd. (No. KWT-2024-01-09-09), and conducted in compliance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) 2.0 Guidelines. For the OTM model, 8-week-old male C57BL/6 mice (20–24 g) were anesthetized via intraperitoneal injection of a 10 ml/kg anesthetic mixture (40 mg/kg ketamine-S, 16 mg/kg 2% xylazine, and 40,000 IE/kg heparin in 0.9% NaCl). A nickel-titanium closed coil spring (Tomy, Fukushima, Japan) was connected between the maxillary left first molar and the anterior alveolar bone using a 0.2 mm-diameter stainless steel wire, applying a stable force of 30 g to move the maxillary left first molar forward (Fig. 1A). On days 0, 2, 4, 6, 8, and 10, 10 µl of mouse IL-33 recombinant protein (210-33-10UG, ThermoFisher SCIENTIFIC) (10 µg/mL), purified anti-mouse ST2 antibody (146604, BioLegend) (100 µg/mL), or PBS was injected into the buccal side of the maxillary left first molar. Twelve days after force application, mice were anesthetized with 5% isoflurane and euthanized via transcardial perfusion with 3.7% paraformaldehyde. The linear distance between the most prominent points of the mesial marginal ridges of the first and second molars was measured using a 50-division dial vernier caliper with an accuracy of 0.02 mm. Tooth movement distance = distance after force application - initial distance. Tissue collection and lysate preparation Maxillary bones were excised, and after extraction of the first molars, periodontal tissues including the periodontal ligament (PDL) and alveolar bone were collected in 5 mL of α-minimum essential medium (α-MEM) supplemented with 1% fetal bovine serum (FBS). Lysates were prepared using a Medimachine (BD Biosciences) and filtered through a 0.22 μm filter (Millipore, MA, USA). Western blot Proteins were extracted using ice-cold RIPA lysis buffer. They were separated by SDS-PAGE electrophoresis, and transferred to PVDF membranes. After blocking in a 5% non-fat milk solution at room temperature, membranes were incubated with primary antibodies at 4 °C overnight. The primary antibodies used in this study included: anti-IL-33 (ab187060, ab207737, Abcam), anti-ST2 (ab194113, Abcam), anti-Cathepsin K (ab37259, Abcam), anti-β-actin (ab8226, Abcam), anti-THRA (PA1-216, Invitrogen) anti-Lamin B1 (12987-1-AP, Proteintech). Membranes were then incubated with HRP-conjugated secondary antibodies, and chemiluminescence detection was performed using enhanced chemiluminescence reagents. Flow cytometry analysis Isolated single-cell suspensions were incubated with fluorochrome-conjugated antibodies, including anti-ST2 (569315, 566311, BD Biosciences), anti-CD11b (#24442, Cell Signaling Technology), anti-CD45 (QA17A26, BioLegend), anti-F4/80 (#64763, Cell Signaling Technology), anti-Ly6C (#68590, Cell Signaling Technology), anti-CD206 (C068C2, BioLegend), and anti-CD14 (29943, Cell Signaling Technology). Flow cytometry was performed using a FACSAria II (BD Biosciences). Immunofluorescence staining Periodontal tissues were fixed in 10% formalin for 24 h, embedded in paraffin, and sectioned into 5 μm-thick slices. After gradient dehydration with ethanol, sections were blocked with 5% goat serum albumin. Sections were incubated with anti-THRA or anti-ST2 at 4 °C overnight, followed by staining with fluorophore-conjugated secondary antibodies at room temperature for 1 h. Sections were mounted using a mounting medium containing DAPI. Isolation and culture of hPDLFs hPDLFs were isolated from caries-free third molars donated by 5 healthy volunteers (19–25 years old), with each donor sample considered an independent biological replicate. All volunteers were informed of the purpose and details of the study, and signed written informed consent forms. The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Review Committee of the Changsha Stomatological Hospital (No. 2024-042). PDL tissues were obtained from the middle third of the root surface. Tissues were digested with 0.1% collagenase I at 37 °C for 30 min. Isolated single cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% FBS and 100 U/mL penicillin-streptomycin. Cells were cultured in an incubator at 37 °C with 100% humidity, 95% air, and 5% CO2. When cells reached 80% confluence, they were passaged, and cells at passage 5 were used for subsequent experiments. hPDLFs were identified by flow cytometry and immunofluorescence: positive for mesenchymal cell surface markers (CD90 and CD105), negative for hematopoietic stem cell surface markers (CD34 and CD45) and mesenchymal stem cell surface marker (STRO-1), and positive for Vimentin (Sup. Figure 1). After treatment with IL-33 (50 ng/ml) for 7 days (with one medium change during this period), alkaline phosphatase activity was detected using an Alkaline Phosphatase Stain Kit (G1480, Solarbio). After treatment with IL-33 (50 ng/ml) for 14 days (with medium changes every 3 days), alizarin red staining was performed to identify calcium nodules. Plasmid construction and transfection The pcDNA3.1-human THRA (NM_001190918) ORF-3xFlag plasmid (F106851, YouBia, China) was transfected into hPDLFs using Lipofectamine 3000 (Invitrogen). Transfection of the empty pcDNA3.1-3xFlag plasmid served as the negative control (NC). Dual-luciferase reporter assay Wild-type and predicted site-mutated IL-33 promoter sequences were inserted into the pGL4.31 vector. Recombinant pGL4.31 plasmids were co-transfected with the pcDNA3.1-THRA plasmid into hPDLFs using Lipofectamine 3000. After 48 h of culture, luciferase activity was measured using the Promega Dual-Luciferase Reporter Assay System, with Renilla luciferase activity used for normalization. Isolation, culture, and treatment of human CD14+ monocytes Blood samples from 5 healthy volunteers (24 ± 1 years old) were used as 5 independent biological replicates. All volunteers were informed of the purpose and details of the study, signed written informed consent forms, and the study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Review Committee of the Changsha Stomatological Hospital (No. 2024-042). Human peripheral blood mononuclear cells (PBMCs) were isolated from blood via Ficoll/Paque Plus centrifugation. CD14+ monocytes were isolated from PBMCs using anti-CD14-conjugated microbeads. Cells were cultured in α-MEM supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin-streptomycin, and 10 ng/ml human M-CSF (HY-P7050, MCE) to induce osteoclast differentiation. Human RANKL (HY-P73386, MCE) (20 ng/ml), human IL-33 (50 ng/ml) (HY-P70475, MCE), and anti-human ST2 antibody (HY-P87275, MCE) (5 µg/ml) were added to the culture medium. After 20 days of continuous culture, cells were stained for tartrate-resistant acid phosphatase (TRAP) Stain Kit (G1492, Solarbio). TRAP+ cells containing three or more nuclei were counted as osteoclasts. At a magnification of 200×, 8 non-overlapping visual fields were randomly selected (covering both the center and the edge of the cell culture dish) for counting. The results are presented as the mean value of the 8 visual fields. Statistical analysis All quantitative data are presented as the mean ± standard deviation (SD) based on at least three independent samples. GraphPad Prism 8.0 was used for statistical analysis. One-way analysis of variance (ANOVA) was used for comparisons among multiple groups. A P-value < 0.05 was considered statistically significant. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Figure 1. hPDLFs were identified by flow cytometry and immunofluorescence. Supplementary Material 2 Author contributions Zhengquan He and Zhenyan Luo contributed to the study conception and design. Material preparation, data collection and analysis were performed by all authors. The first draft of the manuscript was written by Zhengquan He and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. Funding This work was supported by the Research Program of Hunan Provincial Health Commission (202208032486), the Research Project of Changsha Health Commission (KJ-B2023086 and KJ-B2023092) and the Industry Joint Fund of Hunan Provincial Natural Science Foundation (2025JJ80522). Data availability All data supporting the findings of this study are available within the paper and its Supplementary Information. Declarations Ethics approval and consent to participate All animal experiments were approved by the Animal Care and Use Committee of the Beijing Kewei Animal Technology Co., Ltd. (No. KWT-2024-01-09-09), and conducted in compliance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) 2.0 Guidelines. All volunteers were informed of the purpose and details of the study, and signed written informed consent forms. The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Review Committee of the Changsha Stomatological Hospital (No. 2024-042). Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Figure 1. hPDLFs were identified by flow cytometry and immunofluorescence. Supplementary Material 2 Data Availability Statement All data supporting the findings of this study are available within the paper and its Supplementary Information.